NCT02364635View on ClinicalTrials.gov

Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Healthy

Interventions

DRUG

icosabutate

Single dose at each dose levet

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit (CRU) Ltd., Leeds

Sponsors

Lead Sponsor

Pronova BioPharma

All Listed Sponsors

lead

Pronova BioPharma

INDUSTRY